Explore comprehensive CDMO and CRDMO services offered by WuXi Biologics, supporting end-to-end Anlaytical Testing, Drug Development, Drug Discovery and Manufacturing. WuXi Biologics enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China, Germany, Ireland, Singapore, U.S.A
Description: WuXi Biologics is a global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in biologics, with headquarters in Wuxi, Jiangsu, China. The company offers end-to-end solutions that enable partners to discover, develop, and manufacture biologics, positioning itself as a leading technology platform in the pharmaceutical industry. WuXi Biologics is publicly listed on the Hong Kong Stock Exchange (SEHK:2269) and serves a client base that includes 16 of the world's top 20 pharmaceutical companies.
